Correlation Between ZyVersa Therapeutics and Greenwich Lifesciences

Can any of the company-specific risk be diversified away by investing in both ZyVersa Therapeutics and Greenwich Lifesciences at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining ZyVersa Therapeutics and Greenwich Lifesciences into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between ZyVersa Therapeutics and Greenwich Lifesciences, you can compare the effects of market volatilities on ZyVersa Therapeutics and Greenwich Lifesciences and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in ZyVersa Therapeutics with a short position of Greenwich Lifesciences. Check out your portfolio center. Please also check ongoing floating volatility patterns of ZyVersa Therapeutics and Greenwich Lifesciences.

Diversification Opportunities for ZyVersa Therapeutics and Greenwich Lifesciences

0.32

Correlation Coefficient

ZyVersa Therapeutics  Greenwich Lifesciences

Weak diversification

The 3 months correlation between ZyVersa and Greenwich is 0.32. Overlapping area represents the amount of risk that can be diversified away by holding ZyVersa Therapeutics and Greenwich Lifesciences in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Greenwich Lifesciences and ZyVersa Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on ZyVersa Therapeutics are associated (or correlated) with Greenwich Lifesciences. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Greenwich Lifesciences has no effect on the direction of ZyVersa Therapeutics i.e., ZyVersa Therapeutics and Greenwich Lifesciences go up and down completely randomly.

Pair Corralation between ZyVersa Therapeutics and Greenwich Lifesciences

Given the investment horizon of 90 days ZyVersa Therapeutics is expected to under-perform the Greenwich Lifesciences. In addition to that, ZyVersa Therapeutics is 2.76 times more volatile than Greenwich Lifesciences. It trades about -0.02 of its total potential returns per unit of risk. Greenwich Lifesciences is currently generating about -0.01 per unit of volatility. If you would invest  1,359  in Greenwich Lifesciences on October 23, 2024 and sell it today you would lose (72.00) from holding Greenwich Lifesciences or give up 5.3% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

ZyVersa Therapeutics  vs.  Greenwich Lifesciences

ZyVersa Therapeutics

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days ZyVersa Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite weak performance in the last few months, the Stock's basic indicators remain somewhat strong which may send shares a bit higher in February 2025. The current disturbance may also be a sign of long term up-swing for the company investors.

Greenwich Lifesciences

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Greenwich Lifesciences has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong basic indicators, Greenwich Lifesciences is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders.

Pair Trading with ZyVersa Therapeutics and Greenwich Lifesciences

The main advantage of trading using opposite ZyVersa Therapeutics and Greenwich Lifesciences positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if ZyVersa Therapeutics position performs unexpectedly, Greenwich Lifesciences can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Greenwich Lifesciences will offset losses from the drop in Greenwich Lifesciences' long position.

The idea behind ZyVersa Therapeutics and Greenwich Lifesciences pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.